Cargando…

The Role of Bacterial and Fungal Superinfection in Critical COVID-19

Background: The range of reported rates of bacterial and fungal superinfections in patients with a severe course of COVID-19 is wide, suggesting a lack of standardised reporting. Methods: The rates of bacterial and fungal superinfection were assessed using predefined criteria to differentiate betwee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seitz, Tamara, Holbik, Johannes, Grieb, Alexander, Karolyi, Mario, Hind, Julian, Gibas, Georg, Neuhold, Stephanie, Zoufaly, Alexander, Wenisch, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783059/ https://www.ncbi.nlm.nih.gov/pubmed/36560789 http://dx.doi.org/10.3390/v14122785

Ejemplares similares

Rapid Detection of Bacterial and Fungal Pathogens Using the T2MR versus Blood Culture in Patients with Severe COVID-19
por: Seitz, Tamara, et al.
Publicado: (2022)

Percutaneous Auricular Vagus Nerve Stimulation Reduces Inflammation in Critical Covid-19 Patients
por: Seitz, Tamara, et al.
Publicado: (2022)

Randomized controlled study to evaluate the safety and clinical impact of percutaneous auricular vagus nerve stimulation in patients with severe COVID-19
por: Seitz, Tamara, et al.
Publicado: (2023)

Detection of bacteria via multiplex PCR in respiratory samples of critically ill COVID-19 patients with suspected HAP/VAP in the ICU
por: Karolyi, Mario, et al.
Publicado: (2021)

COVID-19-associated myoclonus in a series of five critically ill patients
por: Grieb, Alexander, et al.
Publicado: (2021)

Diagnostik und Therapie von COVID-19 auf der Intensivstation
por: Hoepler, Wolfgang, et al.
Publicado: (2022)

Clinical and Angiographic Features in Three COVID-19 Patients with Takotsubo Cardiomyopathy. Case Report
por: Hoepler, Wolfgang, et al.
Publicado: (2021)

115. Evaluation of the Clinical Impact of the T2MR for the Diagnosis of Bloodstream Infections
por: Seitz, Tamara, et al.
Publicado: (2019)

Bacterial and fungal superinfections in critically ill patients with COVID-19
por: Bassetti, Matteo, et al.
Publicado: (2020)

High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19
por: Karolyi, Mario, et al.
Publicado: (2021)

Antibacterials: Bacterial and fungal superinfections: case report
Publicado: (2022)

PREDICTORS AND OUTCOMES OF BACTERIAL AND FUNGAL SUPERINFECTIONS IN CRITICALLY ILL PATIENTS WITH COVID-19
por: YAQOOB, HAMID, et al.
Publicado: (2021)

Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19
por: Kauer, Victoria, et al.
Publicado: (2023)

Evaluation of Five Commercial SARS-CoV-2 Antigen Tests in a Clinical Setting
por: Seitz, Tamara, et al.
Publicado: (2022)

Diagnosis of COVID-19 using multiple antibody assays in two cases with negative PCR results from nasopharyngeal swabs
por: Traugott, Marianna Theresia, et al.
Publicado: (2020)

Comparison of clinical characteristics among patients infected with alpha vs. delta SARS-CoV-2 variants
por: Rumpf, Benedikt, et al.
Publicado: (2022)

Human recombinant soluble ACE2 in severe COVID-19
por: Zoufaly, Alexander, et al.
Publicado: (2020)

COVID-19 and fungal superinfection
por: Heard, Katie L, et al.
Publicado: (2020)

Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients: Results from a real-life patient cohort
por: Karolyi, Mario, et al.
Publicado: (2020)

Is there a clinical difference between influenza A and B virus infections in hospitalized patients?: Results after routine polymerase chain reaction point-of-care testing in the emergency room from 2017/2018
por: Karolyi, Mario, et al.
Publicado: (2019)

COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria
por: Pawelka, Erich, et al.
Publicado: (2021)

Correction to: COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria
por: Pawelka, Erich, et al.
Publicado: (2021)

Late onset pulmonary embolism in young male otherwise healthy COVID-19 patients
por: Karolyi, M., et al.
Publicado: (2020)

Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort
por: Karolyi, Mario, et al.
Publicado: (2022)

541. The Effect of Early Remdesivir Administration in COVID-19 Disease Progression
por: Platzer, Moritz, et al.
Publicado: (2023)

Successful management of the first reported case in Austria of COVID-19 with ARDS
por: Seitz, T., et al.
Publicado: (2020)

Septic Arthritis of the Hip Complicated by Secondary Fungal Superinfection
por: Matthews, Scott, et al.
Publicado: (2017)

Bacterial superinfection in Zoonotic Cutaneous Leishmaniasis
por: Doudi, Monir, et al.
Publicado: (2012)

Bacterial Superinfection of Amoebic Liver Abscess
por: Dhamrah, Umaima, et al.
Publicado: (2020)

Incidence and clinical outcomes of bacterial superinfections in critically ill patients with COVID-19
por: Yoon, Si Mong, et al.
Publicado: (2023)

A retrospective analysis of clinical features of patients hospitalized with SARS-CoV-2 Omicron variants BA.1 and BA.2
por: Groza, Cristina, et al.
Publicado: (2023)

Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients: A propensity score matched analysis
por: Karolyi, Mario, et al.
Publicado: (2022)

Bacterial and Fungal Superinfections in COVID-19 Patients Hospitalized in an Intensive Care Unit from Timișoara, Romania
por: Novacescu, Alexandru Noris, et al.
Publicado: (2022)

Fungal superinfection in patients with COVID-19: Role of antifungal stewardship?
por: Nestler, Matthew, et al.
Publicado: (2021)

The Superinfection of a Dermoid Cyst
por: Luk, Janelle, et al.
Publicado: (2007)

The prevalence of early‐ and late‐onset bacterial, viral, and fungal respiratory superinfections in invasively ventilated COVID‐19 patients
por: Paparoupa, Maria, et al.
Publicado: (2022)

Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients
por: Buehler, Philipp K., et al.
Publicado: (2021)

The controversial bond between COVID-19 and bacterial superinfections
por: Bonazzetti, Cecilia, et al.
Publicado: (2023)

High Rates of Bacterial Pulmonary Co-Infections and Superinfections Identified by Multiplex PCR among Critically Ill COVID-19 Patients
por: Cohen, Regev, et al.
Publicado: (2021)

Molecular diagnosis of autochthonous human anaplasmosis in Austria – an infectious diseases case report
por: Hoepler, Wolfgang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0ee410kltvfl8fl6uaosil2rgr